High Fibrinogen Levels with Diabetes Mellitus Are Associated with All-Cause and Cardiovascular Mortality in Patients with End-Stage Renal Disease and Acute Coronary Syndrome

Overview

Journal J Inflamm Res

Publisher Dove Medical Press

Date 2024 Oct 23

PMID 39440271

Authors

Enmin Xie

Yaxin Wu

Zixiang Ye

Yanxiang Gao

Jingang Zheng

Affiliations

Soon will be listed here.

Abstract

Objective: As a biomarker of inflammation and a core component in the coagulation pathway, fibrinogen contributes to atherosclerosis and subsequent adverse cardiovascular events and is modified by the occurrence of diabetes mellitus. However, the association between fibrinogen, diabetes status, and mortality in patients with end-stage renal disease (ESRD) and acute coronary syndrome (ACS) remains scarce.

Methods: A multi-center cohort study enrolled 1079 patients with ESRD and ACS between January 2015 and June 2021. Patients were classified into three groups based on fibrinogen tertiles and were further categorized by diabetes status. The primary outcome was all-cause mortality, while the secondary outcome was cardiovascular mortality.

Results: During a median 21.5 months of follow-up, 386 cases of all-cause mortality were recorded, including 262 cases of cardiovascular mortality. Multivariable Cox regression model revealed that patients with the third tertile of fibrinogen and those with diabetes experienced a significantly increased risk of all-cause mortality (fibrinogen: hazard ratio [HR], 1.70; 95% confidence interval [CI], 1.32-2.19; diabetes: HR, 1.36; 95% CI, 1.10-1.68). When patients were stratified by both fibrinogen levels and diabetes status, patients in the third fibrinogen tertile with diabetes had the highest risk of all-cause mortality (HR 2.43, 95% CI 1.69-3.48) compared to those in the first fibrinogen tertile without diabetes. Similar associations were observed for cardiovascular mortality. Notably, incorporating the combined fibrinogen and diabetes status into the Global Registry of Acute Coronary Events (GRACE) score or baseline risk model led to significant improvements in the C-statistics for predicting mortality, surpassing the advancements achieved with any single biomarker.

Conclusion: In patients with ESRD and ACS, elevated fibrinogen and diabetes were associated with an increased risk of all-cause and cardiovascular mortality. Categorizing patients based on fibrinogen levels and diabetes status could provide valuable information for risk stratification of these patients.

References

Barazzoni R, Zanetti M, DAVANZO G, Kiwanuka E, Carraro P, Tiengo A . Increased fibrinogen production in type 2 diabetic patients without detectable vascular complications: correlation with plasma glucagon concentrations. J Clin Endocrinol Metab. 2000; 85(9):3121-5. DOI: 10.1210/jcem.85.9.6779. View

Jensen T, Kierulf P, Sandset P, Klingenberg O, Joo G, Godal H . Fibrinogen and fibrin induce synthesis of proinflammatory cytokines from isolated peripheral blood mononuclear cells. Thromb Haemost. 2007; 97(5):822-9. DOI: 10.1160/th07-01-0039. View

Ang L, Palakodeti V, Khalid A, Tsimikas S, Idrees Z, Tran P . Elevated plasma fibrinogen and diabetes mellitus are associated with lower inhibition of platelet reactivity with clopidogrel. J Am Coll Cardiol. 2008; 52(13):1052-9. DOI: 10.1016/j.jacc.2008.05.054. View

Kostis J . Fibrinogen and coronary artery disease. Hellenic J Cardiol. 2010; 51(5):475. View

Alicic R, Rooney M, Tuttle K . Diabetic Kidney Disease: Challenges, Progress, and Possibilities. Clin J Am Soc Nephrol. 2017; 12(12):2032-2045. PMC: 5718284. DOI: 10.2215/CJN.11491116. View

Granger C, Goldberg R, Dabbous O, Pieper K, Eagle K, Cannon C . Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med. 2003; 163(19):2345-53. DOI: 10.1001/archinte.163.19.2345. View

Tian X, Luo J, Liu F, Qiu Y, Luo F, Zeng L . Prognostic value of fibrinogen-to-albumin ratio combined with coronary calcification score in patients with suspected coronary artery disease. BMC Cardiovasc Disord. 2023; 23(1):181. PMC: 10071697. DOI: 10.1186/s12872-023-03193-z. View

Tomura S, Nakamura Y, Doi M, Ando R, Ida T, Chida Y . Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipid as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis. 1996; 27(6):848-54. DOI: 10.1016/s0272-6386(96)90523-5. View

Lawton J, Tamis-Holland J, Bangalore S, Bates E, Beckie T, Bischoff J . 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2021; 79(2):e21-e129. DOI: 10.1016/j.jacc.2021.09.006. View

10.

He D, Jiao Y, Yu T, Song J, Wen Z, Wu J . Prognostic value of fibrinogen-to-albumin ratio in predicting 1-year clinical progression in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention. Exp Ther Med. 2019; 18(4):2972-2978. PMC: 6755427. DOI: 10.3892/etm.2019.7890. View

11.

Lai A, Bienstock S, Sharma R, Skorecki K, Beerkens F, Samtani R . A Personalized Approach to Chronic Kidney Disease and Cardiovascular Disease: JACC Review Topic of the Week. J Am Coll Cardiol. 2021; 77(11):1470-1479. DOI: 10.1016/j.jacc.2021.01.028. View

12.

Bello A, Okpechi I, Osman M, Cho Y, Htay H, Jha V . Epidemiology of haemodialysis outcomes. Nat Rev Nephrol. 2022; 18(6):378-395. PMC: 8862002. DOI: 10.1038/s41581-022-00542-7. View

13.

Schlieper G, Hess K, Floege J, Marx N . The vulnerable patient with chronic kidney disease. Nephrol Dial Transplant. 2015; 31(3):382-90. DOI: 10.1093/ndt/gfv041. View

14.

Xie E, Ye Z, Wu Y, Zhao X, Li Y, Shen N . Predictive value of the stress hyperglycemia ratio in dialysis patients with acute coronary syndrome: insights from a multi-center observational study. Cardiovasc Diabetol. 2023; 22(1):288. PMC: 10612265. DOI: 10.1186/s12933-023-02036-7. View

15.

Yahagi K, Kolodgie F, Lutter C, Mori H, Romero M, Finn A . Pathology of Human Coronary and Carotid Artery Atherosclerosis and Vascular Calcification in Diabetes Mellitus. Arterioscler Thromb Vasc Biol. 2016; 37(2):191-204. PMC: 5269516. DOI: 10.1161/ATVBAHA.116.306256. View

16.

Yuan T, Yang T, Chen H, Fu D, Hu Y, Wang J . New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis. Redox Biol. 2018; 20:247-260. PMC: 6205410. DOI: 10.1016/j.redox.2018.09.025. View

17.

Liu S, Wu N, Shi H, Dong Q, Dong Q, Gao Y . Fibrinogen is associated with glucose metabolism and cardiovascular outcomes in patients with coronary artery disease. Cardiovasc Diabetol. 2020; 19(1):36. PMC: 7081587. DOI: 10.1186/s12933-020-01012-9. View

18.

Prinsen B, Rabelink T, Beutler J, Kaysen G, de Boer J, Boer W . Increased albumin and fibrinogen synthesis rate in patients with chronic renal failure. Kidney Int. 2003; 64(4):1495-504. DOI: 10.1046/j.1523-1755.2003.00211.x. View

19.

Haffner S, DAgostino Jr R, Mykkanen L, Tracy R, Howard B, Rewers M . Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study. Diabetes Care. 1999; 22(4):562-8. DOI: 10.2337/diacare.22.4.562. View

20.

Undas A, Szuldrzynski K, Brummel-Ziedins K, Tracz W, Zmudka K, Mann K . Systemic blood coagulation activation in acute coronary syndromes. Blood. 2008; 113(9):2070-8. PMC: 2651017. DOI: 10.1182/blood-2008-07-167411. View